In cancer, SOX2 expression frequently coincides with the CSC compartment [16,17,18] from which tumorigenicity, therapy-resistance, and disease relapse are thought to arise [13,19], and moreover with circulating CSC islets as structural correlates of tumor dissemination and metastasis [20,21]. Here, SOX2 is linked to neoplasm.